Open AccessImmunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy
Author(s) -
Sulggi A. Lee,
Helen Byakwaga,
Yap Boum,
Tricia H. Burdo,
Kenneth C. Williams,
Michael M. Lederman,
Yong Huang,
Russell P. Tracy,
Huyen Cao,
Jessica E. Haberer,
Annet Kembabazi,
David R. Bangsberg,
Jeffrey N. Martin,
Peter W. Hunt
Publication year - 2017
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jix113
Subject(s) - hazard ratio , immunology , immune system , cd14 , kynurenine , medicine , biology , tryptophan , confidence interval , amino acid , biochemistry
The plasma kynurenine/tryptophan (KT) ratio, a marker of adaptive immune defects, strongly predicts mortality during treated human immunodeficiency virus (HIV) disease in Ugandans as compared to US-based populations. Here, the KT ratio and T-cell and plasma biomarkers of immune activation were measured among 535 HIV-infected Ugandans prior to ART initiation and at month 6 of viral suppression. The month 6 KT ratio (adjusted hazard ratio [aHR], 2.74), soluble CD14 level (aHR, 2.32), interleukin 6 level (aHR, 2.34), and D-dimer level (aHR, 1.95) were associated with mortality occurring ≥6 months after ART initiation. The KT ratio remained significantly predictive of mortality even after adjustment for the additional biomarkers, suggesting an independent contribution to clinical outcomes in resource-limited settings.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom